SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Relypsa, Inc. Begins Treatment in AMETHYST-DN Trial of RLY5016 for Hyperkalemia in Diabetic Nephropathy Patients with Chronic Kidney Disease